
Catch-bond mechanism of the bacterial adhesin FimH - Nature
Mar 7, 2016 · We reveal a three-state mechanism of FimH catch-bond formation based on crystal structures of all states, kinetic analysis of ligand interaction and molecular dynamics simulations.
FimH and Anti-Adhesive Therapeutics: A Disarming Strategy Against ...
Jul 10, 2020 · The best-characterized bacterial adhesin is FimH, produced by uropathogenic Escherichia coli (UPEC). Hence, a number of high-affinity mono- and polyvalent mannose-based FimH antagonists, characterized by different bioavailabilities, have been reported.
Bacterial adhesin - Wikipedia
FimH is a bacterial adhesin that helps bacteria such as Escherichia coli to bind to host cells and their receptors (here: the human proteins CD48 and TLR4, or mannose residues). [4] Most fimbria of gram-negative bacteria function as adhesins, but in many cases it is a minor subunit protein at the tip of the fimbriae that is the actual adhesin.
Rational Design Strategies for FimH Antagonists: New Drugs …
Recent efforts have culminated in the development of small-molecule mannoside FimH antagonists that target the mannose-binding lectin domain of FimH, inhibiting its function and preventing UPEC from binding mannosylated host cells in …
Type 1 Fimbrial Adhesin FimH Elicits an Immune Response That …
The fimbrial tip-positioned adhesive protein FimH utilizes a shear force-enhanced, so-called catch-bond mechanism of interaction with its receptor, mannose, where the lectin domain of FimH shifts from a low- to a high-affinity conformation upon separation from the anchoring pilin domain.
Escherichia coli adhesion portion FimH functions as an …
Mar 4, 2020 · In this study, we find that FimH, which is an Escherichia coli adhesion portion, induces toll-like receptor 4-dependent and myeloid differentiation protein 2-independent DC maturation in mice in...
FimH confers mannose-targeting ability to Bacillus Calmette
rBCG-S.FimH is a novel BCG strain with significantly improved efficacy against bladder cancer. Since intravesical BCG immunotherapy is the first-line treatment for NMIBC, which accounts for more than 70% of all bladder cancer cases, our results provide a compelling rationale for clinical development …
Structure-based design of an immunogenic, conformationally …
Feb 19, 2025 · FimH is an adhesin positioned on the fimbrial tip which binds to mannosylated proteins on the urinary tract epithelium via its lectin domain (FimH LD). FimH is of interest as a target of vaccines to prevent urinary tract infections (UTI).
Positively selected FimH residues enhance virulence during urinary ...
FimH, the type 1 adhesin, binds mannosylated glycoproteins on the surface of human and murine bladder cells, facilitating bacterial colonization, invasion, and formation of biofilm-like intracellular bacterial communities. The mannose-binding pocket of FimH is invariant among UPEC.
Structural and functional characterization of the FimH adhesin …
Dec 1, 2021 · FimH is the fimbrial adhesin that is at the tip of the organelle and is highly conserved genetically and antigenically among Enterobacteriaceae genera. Perhaps FimF and FimG are required for the integration of FimH into fimbria [4, 5].